Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis

Thorax

Volumn 65, Issue 11, 2010, Pages 985-990

  Douglas, Tonia A ^a,b   Brennan, Siobhain ^b   Berry, Luke ^b   Winfield, Kaye ^b   Wainwright, Claire E ^c,d   Grimwood, Keith ^c,d   Stick, Stephen M ^a,b   Sly, Peter D ^a,b  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CHILD; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SERODIAGNOSIS;

EID: 78149361309     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.132845     Document Type: Article

References (34)

1. Anon. Cystic Fibrosis Foundation Patient Registry 2007 Annual Data Report. Bethesda, Maryland, 2008.
2. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of lower airway function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-5. (Pubitemid 27225208)
3. Gibson RL, Emerson J, Mayer-Hamblett N, et al. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol 2007;42:610-23. (Pubitemid 47022973)
4. Griese M, Muller I, Reinhardt D. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis. Eur J Med Res 2002;7:79-80.
5. Hudson VL, Wielinski CL, Regelmann WE. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J Pediatr 1993;122:854-60.
6. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32:277-87. (Pubitemid 32938876)
7. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293:581-8. (Pubitemid 40171240)
8. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704. (Pubitemid 32417671)
9. Taccetti G, Campana S, Festini F, et al. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005;26:458-61. (Pubitemid 41264209)
10. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100. (Pubitemid 34809519)
11. Armstrong DS, Grimwood K, Carlin JB, et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower airway pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:267-75. (Pubitemid 26159822)
12. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-8. (Pubitemid 29523443)
13. Kappler M, Kraxner A, Reinhardt D, et al. Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis. Thorax 2006;61:684-8. (Pubitemid 44211775)
14. Ratjen F, Walter H, Haug M, et al. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 2007;42:249-55. (Pubitemid 46417698)
15. Tramper-Stranders GA, van der Ent CK, Slieker MG, et al. Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population. Thorax 2006;61:689-93.
16. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-52. (Pubitemid 32105604)
17. West SE, Zeng L, Lee BL, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 2002;287:2958-67. (Pubitemid 34619999)
18. Pressler T, Karpati F, Granstrom M, et al. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 2009;8:37-42.
19. Rao AR, Laxova A, Farrell PM, et al. Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. J Clin Microbiol 2009;47:2483-8.
20. Farrell PM, Govan JR. Pseudomonas serology: confusion, controversy, and challenges. Thorax 2006;61:645-7.
21. Brennan S, Gangell C, Wainwright C, et al. Disease surveillance using bronchoalveolar lavage. Paediatr Respir Rev 2008;9:151-9.
22. Doring G, Hoiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 1983;42:197-201. (Pubitemid 13012453)
23. Lee TW, Brownlee KG, Denton M, et al. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol 2004;37:104-10. (Pubitemid 38120979)
24. UK Cystic Fibrosis Trust Database. Annual Data Report. UK CF Database 2006. Scotland: University of Dundee, 2004.
25. Cystic Fibrosis Australia. Cystic Fibrosis in Australia 2007. 10th Annual Report from the Australasian Cystic Fibrosis Registry. North Ryde, Australia: Cystic Fibrosis Australia, 2009.
26. Jagger K, Robinson D, Franz M, et al. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas protease and exotoxin A in sera from cystic fibrosis patients. J Clin Microbiol 1982;15:1054-8. (Pubitemid 12070853)
27. Pedersen SS, Espersen F, Hoiby N. Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol 1987;25:1830-6.
28. Brett MM, Ghoneim AT, Littlewood JM. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch Dis Child 1986;61:1114-20.
29. Brett MM, Ghoneim AT, Littlewood JM. Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch Dis Child 1987;62:357-61.
30. Montor WR, Huang J, Hu Y, et al. Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays. Infect Immun 2009;77:4877-86.
31. Gutierrez JP, Grimwood K, Armstrong DS, et al. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 2001;17:281-6. (Pubitemid 32600589)
32. da Silva Filho L, Tateno A, Martins K, et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonisation/ infection in cystic fibrosis. Pediatr Pulmonol 2007;42:938-44. (Pubitemid 47549801)
33. Deschaght P, De Baere T, Van Simaey L, et al. Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol 2009;9:244.
34. Fujitani S, Yu VL. Quantitative cultures for diagnosing ventilator-associated pneumonia: a critique. Clin Infect Dis 2006;43(Suppl 2):S106-13. (Pubitemid 44267149)